Asia-Pacific Gastric Cancer Diagnostics Market to 2032

Overview

The Asia-Pacific Gastric Cancer Diagnostics Market is expected to reach a 514.30 USD Million by 2032 and is projected to grow at a CAGR of 12.99% from 2025 to 2032.

Revenue, 2024 (USD Million)

259.36

Forecast, 2032 (USD Million)

514.30

CAGR, 2024 - 2032

12.99%

Report Coverage

Asia-Pacific

Asia-Pacific Gastric Cancer Diagnostics Market 2018-2032 USD Million

Asia-Pacific Gastric Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 259.36 USD Million
Projected Market Size (2032): 514.30 USD Million
CAGR (2025-2032): 12.99%

Key Findings of Asia-Pacific Gastric Cancer Diagnostics Market

The Asia-Pacific Gastric Cancer Diagnostics Market was valued at 259.36 USD Million in 2024.
The Asia-Pacific Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 12.99% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 165.00 USD Million
The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 16.12% during the forecast period from 2024 to 2032.

Asia-Pacific Gastric Cancer Diagnostics Market Scope

Asia-Pacific Gastric Cancer Diagnostics Market Segmentation & Scope

Distribution Channel

Retail Sales
Direct Tender

Product Type

Services
Instruments
Reagents & Consumables

Diagnostic Type

Gastric Cancer Screening Tests/Physical Exam
Confirmatory Test

Stage

Stage 0
Stage III
Stage II
Stage I

Gender

Female
Male

Sample Type

Urine
Blood
Tissue
Stool

End User

Others
Oncology Speciality Clinics
Cancer Research Institutes
Diagnostic Laboratories
Hospitals

Age Group

Pediatric
Adult
Geriatrics

Disease Type

Others
Gastric Lymphoma
Gastrointestinal Stromal Tumor
Carcinoid tumor
Intestinal or Diffuse Adinocarcinoma

Asia-Pacific Gastric Cancer Diagnostics Market Data Coverage Insights

Study Period	2024-2032
Base Year	2020
Unit	Revenue in USD Million
Market Value in 2024	259.36 USD Million
Market Value in 2032	514.30 USD Million
CAGR (2025-2032)	12.99%
Historic Data	2016-2023
Market Segments Covered	Distribution Channel,Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type

Regional Insights:

Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 259.36 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 68.18 USD Million in 2024.

Segments and Scope

Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 165.00 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 14.01 % in forecast period 2025-2032.
Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 144.64 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 14.95 % in forecast period 2025-2032.
Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
- Confirmatory Test is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 150.09 USD Million in the year 2024.
- Confirmatory Test is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.97 % in forecast period 2025-2032.
Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By Stage
- Stage I is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 98.49 USD Million in the year 2024.
- Stage I is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.51 % in forecast period 2025-2032.
Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By Gender
- Male is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 139.29 USD Million in the year 2024.
- Male is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.91 % in forecast period 2025-2032.
Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By Sample Type
- Stool is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 106.17 USD Million in the year 2024.
- Stool is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 16.03 % in forecast period 2025-2032.
Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 90.35 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 16.12 % in forecast period 2025-2032.
Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 139.37 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.25 % in forecast period 2025-2032.
Asia-Pacific Gastric Cancer Diagnostics Market to 2032, By Disease Type
- Intestinal or Diffuse Adinocarcinoma is the largest segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a revenue of 113.79 USD Million in the year 2024.
- Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in Asia-Pacific Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.38 % in forecast period 2025-2032.

Asia-Pacific Gastric Cancer Diagnostics Market Company Share Analysis

Company Name
Myriad Genetics, Inc.
BIOMÉRIEUX
Abbott
General Electric
F. Hoffmann-La Roche Ltd.

Asia-Pacific Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

Asia-Pacific Gastric Cancer Diagnostics Market Company Profiling

Industry Related Reports

Asia-Pacific Breast Lesion Localization Methods Market

Europe Breast Lesion Localization Methods Market

North America Breast Lesion Localization Methods Market

Middle East & Africa Breast Lesion Localization Methods Market

South America Breast Lesion Localization Methods Market

Australia Breast Lesion Localization Methods Market

Belgium Breast Lesion Localization Methods Market

Brazil Breast Lesion Localization Methods Market

Canada Breast Lesion Localization Methods Market

China Breast Lesion Localization Methods Market

Frequently Asked Questions

What are the primary segments covered in the Asia-Pacific Gastric Cancer Diagnostics Market?

The Asia-Pacific Gastric Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type.

What is the current market size of the Asia-Pacific Gastric Cancer Diagnostics Market?

Asia-Pacific Gastric Cancer Diagnostics Market was valued at USD 259.36(Revenue in USD Million) in 2020.

What is the expected growth rate of the Asia-Pacific Gastric Cancer Diagnostics Market?

Asia-Pacific Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 12.99% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Asia-Pacific Gastric Cancer Diagnostics Market?

The Direct Tender segment is expected to dominate the Asia-Pacific Gastric Cancer Diagnostics Market, holding a largest market share of 165.00 USD Million in 2024